Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Microorganisms|November 27, 2025
Harnessing a Surface Water-Based Multifaceted Approach to Combat Zoonotic Viruses: A Rural Perspective from Bangladesh and ChinaYizhe Wu, Yuqing Long, Xueling Yang, et al.
Translational Cancer Research|February 4, 2022
Bruton's tyrosine kinase inhibitors in primary central nervous system lymphoma-evaluation of anti-tumor efficacy and brain distributionHaifeng Yu, Haiying Kong, Cong Li, et al.
Journal of Biomedicine & Biotechnology|October 25, 2012
Comparison of acute recoil between bioabsorbable poly-L-lactic acid XINSORB stent and metallic stent in porcine modelYizhe Wu, Li Shen, Qibing Wang, et al.
Bioactive Materials|July 9, 2020
High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivoShanshan Chen, Zhifeng Yao, Yongbiao Guan, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 24, 2023
Dynamic perfusion SPECT for functional evaluation in symptomatic patients with myocardial bridgingRende Xu, Hao Yang, Jie Zhang, et al.
The International Journal of Cardiovascular Imaging|March 2, 2018
Healing score of the Xinsorb scaffold in the treatment of de novo lesions: 6-month imaging outcomesXucheng Lv, Li Shen, Yizhe Wu, et al.
Medical Engineering & Physics|July 23, 2025
A coronary atherectomy system with a novel burr design for two-phase operationLeilei Ma, Zhe Wang, Jiaqi Yang, et al.
Journal of Hazardous Materials|June 15, 2026
Inhalation toxicity assessment of imidazolium ionic liquids by a physiology-based high-throughput lung-burden computational modelWanjun Zhang, Yizhe Wu, Jiayin Sun, et al.
European Journal of Medicinal Chemistry|July 14, 2019
Discovery of pyrazole-thiophene derivatives as highly Potent, orally active Akt inhibitorsWenhu Zhan, Jinxin Che, Lei Xu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 12, 2016
Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary arteryYizhe Wu, Li Shen, Lei Ge, et al.
Pageof 6